📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: eTherapeutics

1.1 - Company Overview

eTherapeutics Logo

eTherapeutics

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of drug discovery and development solutions using proprietary computational systems to analyze and predict medicine–cell interactions, optimizing efficacy and minimal side effects. Includes HepNet™ computational biology and GalOmic™ RNAi platforms, with candidates ETX-312 (MASH), ETX-407 (dAMD), ETX-148 (haemophilia), and ETX-291 (cardiometabolic).

Products and services

  • HepNet™: A custom-engineered computational biology platform focused on hepatocytes that swiftly predicts medicine–cell interactions to identify novel gene targets and improve drug design decisions
  • GalOmic™: A proprietary RNAi platform that produces GalNAc-siRNA therapeutics targeting disease-associated genes in hepatocytes, streamlining creation of targeted medicines
  • ETX-312: A preclinical-stage therapeutic candidate for metabolic dysfunction-associated steatohepatitis (MASH) showing promising results in preclinical models

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to eTherapeutics

Pharvaris Logo

Pharvaris

HQ: Switzerland Website
  • Description: Provider of oral bradykinin B2-receptor antagonist therapies in clinical development for hereditary angioedema (HAE), including deucrictibant; PHVS416 immediate-release capsules for acute HAE attacks; PHVS719 extended-release tablets for HAE prophylaxis; and the RAPIDe-1, RAPIDe-2, and CHAPTER-1 clinical trials evaluating these candidates.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pharvaris company profile →
Vidara Therapeutics Logo

Vidara Therapeutics

HQ: United States Website
  • Description: Provider of specialty pharmaceutical offerings, creating value through accretive product acquisitions or license agreements, sound marketing and distribution, and life cycle management; incorporated in 2003 and based in Dublin, Ireland.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vidara Therapeutics company profile →
Aro Biotherapeutics Logo

Aro Biotherapeutics

HQ: United States Website
  • Description: Provider of tissue-targeted genetic medicines leveraging Centyrins, a proprietary small engineered protein platform, for targeted delivery to specific cells. Develops oligonucleotide-based therapeutics that modulate gene expression, including ABX1100, a Centyrin-siRNA conjugate targeting CD71 and Gys1 mRNA for Pompe disease to reduce muscle glycogen.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aro Biotherapeutics company profile →
Bioverativ Logo

Bioverativ

HQ: United States Website
  • Description: Provider of innovative therapies for hemophilia and other rare blood disorders through world-class research, development and commercialization by a global biotechnology company dedicated to transforming lives.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bioverativ company profile →
Brabant Pharma Logo

Brabant Pharma

HQ: Vietnam Website
  • Description: Provider of a late-stage oral treatment, Brabafen, under development for children with Dravet Syndrome (severe myoclonic epilepsy of infancy), a rare childhood epilepsy associated with catastrophic seizures resulting in mental and cognitive impairment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Brabant Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for eTherapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to eTherapeutics

2.2 - Growth funds investing in similar companies to eTherapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for eTherapeutics

4.2 - Public trading comparable groups for eTherapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to eTherapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About eTherapeutics

What does eTherapeutics do?

eTherapeutics is a provider of drug discovery and development solutions using proprietary computational systems to analyze and predict medicine–cell interactions, optimizing efficacy and minimal side effects. Includes HepNet™ computational biology and GalOmic™ RNAi platforms, with candidates ETX-312 (MASH), ETX-407 (dAMD), ETX-148 (haemophilia), and ETX-291 (cardiometabolic).

Who are eTherapeutics's competitors?

eTherapeutics's competitors and similar companies include Pharvaris, Vidara Therapeutics, Aro Biotherapeutics, Bioverativ, and Brabant Pharma.

Where is eTherapeutics headquartered?

eTherapeutics is headquartered in United Kingdom.

How many employees does eTherapeutics have?

eTherapeutics has 1,000 employees 🔒.

When was eTherapeutics founded?

eTherapeutics was founded in 2010 🔒.

What sector and industry vertical is eTherapeutics in?

eTherapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for eTherapeutics

Who are the top strategic acquirers in eTherapeutics's sector and industry

Top strategic M&A buyers and acquirers in eTherapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for eTherapeutics?

Top strategic M&A buyers groups and sectors for eTherapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in eTherapeutics's sector and industry vertical

Which are the top PE firms investing in eTherapeutics's sector and industry vertical?

Top PE firms investing in eTherapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in eTherapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in eTherapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in eTherapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to eTherapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in eTherapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for eTherapeutics?

The key public trading comparables and valuation benchmarks for eTherapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for eTherapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for eTherapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in eTherapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for eTherapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in eTherapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in eTherapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for eTherapeutics